Cargando…

Endocannabinoid Receptors Gene Expression in Morbidly Obese Women with Nonalcoholic Fatty Liver Disease

Background. Recent reports suggest a role for the endocannabinoid system in the pathology of nonalcoholic fatty liver disease (NAFLD). The aim of this study was to investigate the relationship between liver expression of cannabinoid (CB) receptor subtypes, CB1 and CB2, in morbidly obese (MO) women w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Auguet, Teresa, Berlanga, Alba, Guiu-Jurado, Esther, Terra, Ximena, Martinez, Salomé, Aguilar, Carmen, Filiu, Elisa, Alibalic, Ajla, Sabench, Fàtima, Hernández, Mercé, Del Castillo, Daniel, Richart, Cristóbal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017805/ https://www.ncbi.nlm.nih.gov/pubmed/24864249 http://dx.doi.org/10.1155/2014/502542

Ejemplares similares

Expression of STING in Women with Morbid Obesity and Nonalcoholic Fatty Liver Disease
por: Bertran, Laia, et al.
Publicado: (2023)

miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease
por: Auguet, Teresa, et al.
Publicado: (2016)

Altered Fatty Acid Metabolism-Related Gene Expression in Liver from Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
por: Auguet, Teresa, et al.
Publicado: (2014)

Interleukin-17A Gene Expression in Morbidly Obese Women
por: Zapata-Gonzalez, Fernando, et al.
Publicado: (2015)

Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
por: Aragonès, Gemma, et al.
Publicado: (2016)

PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
por: Aragonès, Gemma, et al.
Publicado: (2016)

Adipo/cytokines in atherosclerotic secretomes: increased visfatin levels in unstable carotid plaque
por: Auguet, Teresa, et al.
Publicado: (2016)

Hepcidin in morbidly obese women with non-alcoholic fatty liver disease
por: Auguet, Teresa, et al.
Publicado: (2017)

Downregulation of de Novo Fatty Acid Synthesis in Subcutaneous Adipose Tissue of Moderately Obese Women
por: Guiu-Jurado, Esther, et al.
Publicado: (2015)

LC/MS-Based Untargeted Metabolomics Study in Women with Nonalcoholic Steatohepatitis Associated with Morbid Obesity
por: Bertran, Laia, et al.
Publicado: (2023)

Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis
por: Auguet, Teresa, et al.
Publicado: (2020)

New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women
por: Auguet, Teresa, et al.
Publicado: (2011)

The Role of Olfactomedin 2 in the Adipose Tissue–Liver Axis and Its Implication in Obesity-Associated Nonalcoholic Fatty Liver Disease
por: Barrientos-Riosalido, Andrea, et al.
Publicado: (2023)

Deregulated Serotonin Pathway in Women with Morbid Obesity and NAFLD
por: Binetti, Jessica, et al.
Publicado: (2020)

Circulating Levels of Pro-Neurotensin and Its Relationship with Nonalcoholic Steatohepatitis and Hepatic Lipid Metabolism
por: Villar, Beatriz, et al.
Publicado: (2021)

Expression of Jejunal Taste Receptors in Women with Morbid Obesity
por: Bertran, Laia, et al.
Publicado: (2021)

Increased Hepatic ATG7 mRNA and ATG7 Protein Expression in Nonalcoholic Steatohepatitis Associated with Obesity
por: Barrientos-Riosalido, Andrea, et al.
Publicado: (2023)

Deregulation of Secreted Frizzled-Related Protein 5 in Nonalcoholic Fatty Liver Disease Associated with Obesity
por: Bertran, Laia, et al.
Publicado: (2021)

The Potential Protective Role of RUNX1 in Nonalcoholic Fatty Liver Disease
por: Bertran, Laia, et al.
Publicado: (2021)

New Insights of OLFM2 and OLFM4 in Gut-Liver Axis and Their Potential Involvement in Nonalcoholic Fatty Liver Disease
por: Bertran, Laia, et al.
Publicado: (2022)

Increased Secreted Frizzled-Related Protein 5 mRNA Expression in the Adipose Tissue of Women with Nonalcoholic Fatty Liver Disease Associated with Obesity
por: Bertran, Laia, et al.
Publicado: (2022)

LC/MS-Based Untargeted Metabolomics Analysis in Women with Morbid Obesity and Associated Type 2 Diabetes Mellitus
por: Auguet, Teresa, et al.
Publicado: (2023)

Molecular pathways in non-alcoholic fatty liver disease
por: Berlanga, Alba, et al.
Publicado: (2014)

Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease
por: Aragonès, Gemma, et al.
Publicado: (2019)

Are Ingested or Inhaled Microplastics Involved in Nonalcoholic Fatty Liver Disease?
por: Auguet, Teresa, et al.
Publicado: (2022)

Predictive Biomarkers of COVID-19 Severity in SARS-CoV-2 Infected Patients with Obesity and Metabolic Syndrome
por: Perpiñan, Carles, et al.
Publicado: (2021)

Identification of the Potential Molecular Mechanisms Linking RUNX1 Activity with Nonalcoholic Fatty Liver Disease, by Means of Systems Biology
por: Bertran, Laia, et al.
Publicado: (2022)

Targeted metabolomic approach in men with carotid plaque
por: Auguet, Teresa, et al.
Publicado: (2018)

Quantitative and Topographic Analysis by Immunohistochemical Expression of Ghrelin Gastric Cells in Patients with Morbid Obesity
por: Parada D, David, et al.
Publicado: (2020)

Endocannabinoid System Components as Potential Biomarkers in Psychiatry
por: Navarrete, Francisco, et al.
Publicado: (2020)

The Endocannabinoid System as Prognostic Biomarker of the Obstructive Sleep Apnea Morbidity in COVID-19-Recovered Individuals
por: Murillo-Rodríguez, Eric
Publicado: (2021)

Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism
por: Jové, Mariona, et al.
Publicado: (2016)

Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study
por: Guasch, Alba, et al.
Publicado: (2012)

Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression
por: Gallego-Landin, Ines, et al.
Publicado: (2021)

Endocannabinoids and Schizophrenia
por: Desfossés, Joëlle, et al.
Publicado: (2010)

Endocannabinoids and Reproduction
por: Meccariello, Rosaria, et al.
Publicado: (2014)

Endocannabinoids and Immunity
por: Chiurchiù, Valerio
Publicado: (2016)

Endocannabinoids in the Gut
por: DiPatrizio, Nicholas V.
Publicado: (2016)

Genetics of Obesity in East Asians
por: Sun, Chang, et al.
Publicado: (2020)

Genetics of Body Fat Distribution: Comparative Analyses in Populations with European, Asian and African Ancestries
por: Sun, Chang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i8uhcqqm8npredvopitc8ouum8